| scholarly article | Q13442814 |
| P2093 | author name string | F Stewart | |
| J A Leveque | |||
| J D Koenig | |||
| J Henneberry | |||
| J Trussell | |||
| K D LaGuardia | |||
| R London | |||
| S Borden | |||
| S Wysocki | |||
| T G Wilson | |||
| P2860 | cites work | Tubal sterilization: findings in a large prospective study. | Q52096047 |
| Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. | Q52863543 | ||
| International experience with NORPLANT and NORPLANT-2 contraceptives. | Q53415656 | ||
| Long-Acting, More Effective Copper T IUDs: A Summary of U.S. Experience, 1970-75 | Q56049864 | ||
| Emergency contraceptive pills: a simple proposal to reduce unintended pregnancies | Q67988261 | ||
| Public funding for contraceptive, sterilization and abortion services, fiscal year 1992 | Q72787112 | ||
| The Accessibility of Abortion Services in the United States | Q22305748 | ||
| Efficacy of the Simultaneous Use of Condoms and Spermicides | Q28297926 | ||
| The effectiveness of postcoital hormonal contraception | Q35657874 | ||
| Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use | Q39237883 | ||
| The lifetime cost of treating a person with HIV. | Q43838666 | ||
| Oral contraceptives and reproductive cancers: weighing the risks and benefits | Q44117225 | ||
| The sexual and reproductive behavior of American women, 1982-1988. | Q44566565 | ||
| Abortion services in the United States, 1991 and 1992. | Q46855132 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | birth control | Q122224 |
| P304 | page(s) | 494-503 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | American Journal of Public Health | Q4744266 |
| P1476 | title | The economic value of contraception: a comparison of 15 methods | |
| P478 | volume | 85 |
| Q52889848 | A qualitative study of perceptions, attitudes, and experiences of long-term levonorgestrel implant users. |
| Q74691652 | Adolescent pregnancy prevention in managed care |
| Q24681771 | Analysis of the autoimmune epitopes on human testicular NASP using recombinant and synthetic peptides |
| Q45179975 | Benefit-risk assessment of the levonorgestrel intrauterine system in contraception |
| Q39469247 | Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls |
| Q71553555 | Condom use among female commercial sex workers in Nevada's legal brothels |
| Q47772702 | Continuation rates with a levonorgestrel-releasing contraceptive implant (Norplant). A prospective study in Belgium |
| Q34920073 | Contraceptive needs of the perimenopausal woman |
| Q40836450 | Contraceptive use: the US perspective |
| Q24631004 | Cost effectiveness of contraceptives in the United States |
| Q81784427 | Cost savings from the provision of specific methods of contraception in a publicly funded program |
| Q35752383 | Cost-Effectiveness of Introducing the SILCS Diaphragm in South Africa |
| Q46609935 | Cost-savings from the provision of specific contraceptive methods in 2009. |
| Q74536177 | Counseling to prevent unintended pregnancies: measuring its value |
| Q34750038 | Current opinion: consensus statement on intrauterine contraception |
| Q35183917 | Economic analysis of contraceptives for women |
| Q74186223 | Economic analysis of long-term reversible contraceptives. Focus on Implanon |
| Q73581465 | Emergency contraception--parsimony and prevention in the medicine cabinet |
| Q34189356 | Estimating the effectiveness of emergency contraceptive pills |
| Q80396224 | Expanded state-funded family planning services: estimating pregnancies averted by the Family PACT Program in California, 1997-1998 |
| Q72123163 | Failing to prevent unintended pregnancy is costly |
| Q24613481 | Family planning and the burden of unintended pregnancies |
| Q28385008 | Health authority commissioning for quality in contraception services |
| Q34089803 | Health economics of contraception |
| Q34143320 | How safe is emergency contraception? |
| Q35138280 | Impact of pay for performance on prescribing of long-acting reversible contraception in primary care: an interrupted time series study |
| Q34089771 | Implantable contraception |
| Q77677672 | Implantable contraceptives for women |
| Q35025605 | Intrauterine contraception: study to evaluate clinical practice and to increase utilization |
| Q33922310 | Intrauterine device and upper-genital-tract infection |
| Q77529228 | Intrauterine device practice guidelines: patient types |
| Q46283426 | Intrauterine devices: mechanisms of action, safety, and efficacy |
| Q56910623 | Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda |
| Q33502678 | Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability |
| Q49222352 | Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial |
| Q33586119 | Managed care and unintended pregnancy: testing the limits of prevention |
| Q74439449 | Modeling the cost and outcomes of pharmacist-prescribed emergency contraception |
| Q42107992 | Modelling cost-effectiveness of different vasectomy methods in India, Kenya, and Mexico |
| Q37608386 | Non-oral reversible contraceptive methods |
| Q77081808 | Norplant selection and satisfaction among low-income women |
| Q30669838 | Performance indicators in women's health: incorporating women's health in the health plan employer data and information set (HEDIS). |
| Q34750046 | Perpetuating negative attitudes about the intrauterine device: textbooks lag behind the evidence |
| Q51326264 | Predictors of men's acceptance of modern contraceptive practice: study in rural Vietnam. |
| Q73512493 | Preventing unintended pregnancy: the cost-effectiveness of three methods of emergency contraception |
| Q33578698 | Preventing unintended teenage pregnancies and reducing their adverse effects |
| Q36962498 | Prior contraceptive use among women who gave birth in the US-Mexico border region, 2005: the Brownsville-Matamoros Sister City Project for Women's Health |
| Q64131239 | Quality measures for unintended pregnancy prevention in health care services: opportunities and challenges |
| Q45196991 | Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK. |
| Q35089920 | Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants |
| Q33899805 | Safety and effectiveness of vasectomy |
| Q33540807 | State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices |
| Q34808455 | Sterilization in the United States |
| Q34126221 | Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception |
| Q33879885 | The "boom and bust phenomenon": the hopes, dreams, and broken promises of the contraceptive revolution |
| Q52965723 | The benefit of health insurance coverage of contraceptives in a population-based sample. |
| Q46540930 | The effect of Medicaid family planning expansions on unplanned births |
| Q34089763 | The intrauterine contraceptive device |
| Q53710808 | The intrauterine contraceptive device: an acceptable alternative to sterilization in young women. |
| Q34466951 | The perforated intrauterine device: endoscopic retrieval. |
| Q40982921 | The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization |
| Q43339418 | The trimonthly combination oral contraceptive regimen: is it cost effective? |
| Q44956685 | The use of URYX for reversible vasectomy in a rabbit model |
| Q40697645 | Use of contraceptive methods among homeless women for protection against unwanted pregnancies and sexually transmitted diseases: prior use and willingness to use in the future |
| Q34541970 | Users' perspectives on implantable contraceptives for women |
| Q58053701 | Uterine factors and risk of pregnancy in IUD users: a nested case-control study |
| Q50857324 | What is the actual cost of providing the intrauterine system for contraception in a UK community sexual and reproductive health setting? |
Search more.